Stockholder's Equity and Employee Benefit Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2023	Dec. 31, 2022
Number of Shares
Outstanding at December 31, 2022	13,133,446
Granted	0
Exercised	0
Forfeited	(22,001)
Expired	(2,325,356)
Outstanding, vested and expected to vest at March 31, 2023	10,786,089	13,133,446
Vested and exercisable at March 31, 2023	8,770,544
Weighted Average Exercise Price
Outstanding at December 31, 2022	$ 16.24
Granted	0
Exercised	0
Forfeited	20.18
Expired	16.61
Outstanding, vested and expected to vest at March 31, 2023	16.15	$ 16.24
Vested and exercisable at March 31, 2023	$ 16.59
Outstanding at December 31, 2022	$ 0
Outstanding, vested and expected to vest, Aggregate Intrinsic Value, at March 31, 2023	1,918	$ 0
Vested and exercisable at March 31, 2023	$ 0
Outstanding, vested and expected to vest, Weighted Average Remaining Contractual Term	4 years 8 months 12 days	4 years 2 months 12 days
Vested and exercisable, Weighted Average Remaining Contractual Term	4 years 8 months 12 days

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.